Tokyo Tape
Sign in
← Nippon Kayaku

Quarterly report · Q2

4272.TEDINET S100S30O
Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥97.9bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥198.4bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥102.7bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥4.8bn2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥13.6bn2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥8.3bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥23.0bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥16.6bn2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥8.8bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥16.4bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥6.1bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥15.0bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥11.3bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥6.1bn2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥11.3bn2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥349.2bnat 2023-09-30Cons.Assets
Total assets¥322.9bnat 2023-03-31Cons.Assets
Total assets¥329.5bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥81.7bnat 2023-09-30Cons.Liabilities
Total liabilities¥67.8bnat 2023-03-31Cons.Liabilities
Net assets / equity¥267.5bnat 2023-09-30Cons.Net assets
Net assets / equity¥255.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥259.2bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥50.5bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥48.1bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥57.2bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥53.1bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥52.6bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥53.0bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥10.5bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥20.0bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥12.0bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥12.2bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥15.2bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥9.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥2.3bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥8.0bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥6.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥36.742023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥20.692023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥89.362022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥67.042022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥31.632022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥36.722023-04-01 → 2023-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥89.332022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥67.022022-04-01 → 2022-09-30Cons.Diluted earnings per share (5-year summary)
Equity ratio76.3%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio78.7%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio78.4%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥78m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥78m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥3.9bn
jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue2023-04-01 → 2023-09-30¥28.0bn
jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue external2023-04-01 → 2023-09-30¥27.9bn
jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥77m
jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segmentsegment profit2023-04-01 → 2023-09-30¥2.3bn
jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segmentrevenue2023-04-01 → 2023-09-30¥30.5bn
jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segmentrevenue external2023-04-01 → 2023-09-30¥30.5bn
jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥0
jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segmentsegment profit2023-04-01 → 2023-09-30¥3.1bn
jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segmentrevenue2023-04-01 → 2023-09-30¥39.5bn
jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segmentrevenue external2023-04-01 → 2023-09-30¥39.5bn
jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segmentsegment profit2023-04-01 → 2023-09-30¥3.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥98.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥97.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥78m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥8.7bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥82m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥82m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥3.7bn
jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue2022-04-01 → 2022-09-30¥36.7bn
jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue external2022-04-01 → 2022-09-30¥36.6bn
jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥82m
jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segmentsegment profit2022-04-01 → 2022-09-30¥7.2bn
jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segmentrevenue2022-04-01 → 2022-09-30¥30.0bn
jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segmentrevenue external2022-04-01 → 2022-09-30¥30.0bn
jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥0
jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segmentsegment profit2022-04-01 → 2022-09-30¥5.4bn
jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segmentrevenue2022-04-01 → 2022-09-30¥36.2bn
jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segmentrevenue external2022-04-01 → 2022-09-30¥36.2bn
jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segmentsegment profit2022-04-01 → 2022-09-30¥4.7bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥102.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥102.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥82m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥17.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 573
ItemContextValueUnit
Bonuses and allowance general and administrative expensesCurrentYTDDuration448000000JPY
Retirement benefit expenses gaPrior1YTDDuration80000000JPY
Retirement benefit expenses gaCurrentYTDDuration92000000JPY
Depreciation gaPrior1YTDDuration325000000JPY
Depreciation gaCurrentYTDDuration359000000JPY
Research and development expenses sgaPrior1YTDDuration6058000000JPY
Research and development expenses sgaCurrentYTDDuration6974000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E00836-000MobilityAndImagingBusinessUnitReportableSegmentMember36154000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E00836-000FineChemicalsBusinessUnitReportableSegmentMember36611000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E00836-000LifeScienceBusinessUnitReportableSegmentMember29963000000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember102728000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration102728000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E00836-000MobilityAndImagingBusinessUnitReportableSegmentMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E00836-000FineChemicalsBusinessUnitReportableSegmentMember82000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E00836-000LifeScienceBusinessUnitReportableSegmentMember0JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember82000000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-82000000JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E00836-000MobilityAndImagingBusinessUnitReportableSegmentMember36154000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E00836-000FineChemicalsBusinessUnitReportableSegmentMember36693000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E00836-000LifeScienceBusinessUnitReportableSegmentMember29963000000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember102811000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-82000000JPY
Net salesPrior1YTDDuration102728000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E00836-000MobilityAndImagingBusinessUnitReportableSegmentMember4667000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E00836-000FineChemicalsBusinessUnitReportableSegmentMember7155000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E00836-000LifeScienceBusinessUnitReportableSegmentMember5405000000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember17228000000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-3668000000JPY
Operating incomePrior1YTDDuration13559000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E00836-000MobilityAndImagingBusinessUnitReportableSegmentMember39467000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E00836-000FineChemicalsBusinessUnitReportableSegmentMember27943000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E00836-000LifeScienceBusinessUnitReportableSegmentMember30497000000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember97908000000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration97908000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E00836-000MobilityAndImagingBusinessUnitReportableSegmentMember－JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E00836-000FineChemicalsBusinessUnitReportableSegmentMember77000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E00836-000LifeScienceBusinessUnitReportableSegmentMember0JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember78000000JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-78000000JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E00836-000MobilityAndImagingBusinessUnitReportableSegmentMember39467000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E00836-000FineChemicalsBusinessUnitReportableSegmentMember28021000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E00836-000LifeScienceBusinessUnitReportableSegmentMember30498000000JPY
Net salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember97987000000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember-78000000JPY
Net salesCurrentYTDDuration97908000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E00836-000MobilityAndImagingBusinessUnitReportableSegmentMember3318000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass